Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
rabeprazole (rabeprazole sodium)
Apotex Inc.
A02BC04
rabeprazole (rabeprazole sodium)
20mg
tablets enteric-coated
(100) plastic container
Prescription
Registered
2015-04-16
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr APO-RABEPRAZOLE rabeprazole sodium This leaflet is Part III of a three-part "Product Monograph" published when APO-RABEPRAZOLE was approved for sale in Canada and is designed specifically for Consumers. This leaflet is a summary and will not tell you everything about Apo- Rabeprazole. Contact your doctor or pharmacist if you have any questions about the drug. ABOUT THIS MEDICATION Read this leaflet carefully. It contains general information about Apo-Rabeprazole tablets that you should know in addition to the specific advice from your doctor or pharmacist. instructions regarding how and when to take Apo-Rabeprazole tablets. WHAT THE MEDICATION IS USED FOR: APO-RABEPRAZOLE IS THE BRAND NAME FOR A DRUG CALLED RABEPRAZOLE SODIUM. The most common uses of Apo-Rabeprazole tablets are: symptomatic relief and healing of duodenal ulcers; symptomatic relief and healing of stomach ulcers; healing of gastroesophageal reflux disease (GERD) and relief of its symptoms such as burning sensation rising from the chest towards the neck (heartburn) and the flow of bitter/sour juice into the mouth (regurgitation); treatment of symptoms (i.e. heartburn and regurgitation) of non-erosive reflux disease (NERD); maintenance treatment of gastroesophageal reflux disease (GERD). Apo-Rabeprazole tablets may also be used in rare conditions - produces large amounts of acid. When used with certain antibiotics, Apo-Rabeprazole is also used for the treatment of ulcers caused by infection with a bacterium called _Helicobacter pylori _ ( _H. pylori_ ), and to help reduce the risk of these ulcers from coming back. If the doctor is prescribing therapy with a combination of Apo-Rabeprazole and antibiotics (amoxicillin and clarithromycin) the pharmacist should provide you with information on the antibiotics. WHAT IT DOES: Apo-Rabeprazole is a medicine called a proton pump inhibitor (PPI). Apo-Rabeprazole works by reducing the amount of acid made in your stomach. WHEN IT SHOULD NOT BE USED: If you Read the complete document
APPENDIX 1.9 THE SUMMARY OF THE PRODUCT CHARACTERISTICS (SMPC) _ _ Page 1 of 22 1. NAME OF THE MEDICINAL PRODUCT Apo-Rabeprazole Tablets 10 mg and 20 mg (Rabeprazole Tablets 10 mg and 20 mg) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION STRENGTH (LABEL CLAIM): %W/W 10 MG 20 MG COMPONENT FUNCTION QUANTITY MG /TABLET QUANTITY MG /TABLET CORE TABLET: Rabeprazole Sodium* Active 14.3 10.01 20.02 Anhydrous Lactose NF** Diluent/Filler 83.5 58.45 116.9 Colloidal Silicon Dioxide NF Glidant 0.2 0.14 0.28 Magnesium Stearate NF Lubricant 2.0 1.4 2.8 TOTAL CORE WEIGHT 100.0 70.0 100.0 COATING SOLUTION: Methacrylic Acid Copolymer Dispersion NF † Binder 60 50.0 † 80 † Red Ferric Oxide NF Orange Shade Colorant 2.0 0.5 N/A Yellow Ferric Oxide NF Colorant -- N/A 0.8 Titanium Dioxide USP Opacifier/ Pigment 18.0 4.5 7.2 Talc USP 500 Mesh Lubricant 14.0 3.5 5.6 Triethyl Citrate NF Plasticizer 6.0 1.5 2.4 Purified Water USP*** Solvent -- 100.0 160.0 TOTAL COATING SOLUTION 160 256 TOTAL COATING SOLIDS 25.0 40.0 TOTAL COATED TABLET WEIGHT 100.0 95.0 180.0 * Potency adjustment, based on 100% active assay ** Varies according to potency, based on 100% active assay *** Water is evaporated off during the manufacturing process † Contains 30% solids 3. PHARMACEUTICAL FORM Film-Coating Tablets APPENDIX 1.9 THE SUMMARY OF THE PRODUCT CHARACTERISTICS (SMPC) _ _ Page 2 of 22 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS APO-RABEPRAZOLE (Rabeprazole sodium) is indicated for: • Treatment of conditions where a reduction of gastric acid secretion is required, such as: 1. Symptomatic relief and healing of erosive or ulcerative gastro esophageal reflux disease (GERD). 2. Long-term maintenance of healing of erosive or ulcerative gastro esophageal reflux disease (GERD). 3. Treatment of symptoms (i.e. heartburn and regurgitation) in symptomatic gastro esophageal reflux disease (GERD), also called non-erosive reflux disease (NERD). 4. Symptomatic relief and healing of duodenal ulcers. 5. Symptomatic relief and healing of gastric ulcers. 6. Lon Read the complete document